| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 326,225 | 321,199 | 318,143 | 365,333 | | Cost of Revenue | 257,294 | 255,541 | 269,448 | 334,440 | | | Gross Profit | 68,931 | 65,658 | 48,695 | 30,893 | | | Operating Expenses | | Research Development | 8,650 | 8,953 | 8,746 | 7,870 | | Selling General and Administrative | 26,628 | 25,517 | 13,780 | 15,632 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 33,653 | 31,188 | 26,169 | 7,391 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 684 | 1,310 | (269) | (1,347) | | Earnings Before Interest And Taxes | 31,939 | 32,212 | 25,093 | 5,592 | | Interest Expense | 1,508 | 1,585 | 1,842 | 2,431 | | Income Before Tax | 30,431 | 30,627 | 23,251 | 3,161 | | Income Tax Expense | 10,843 | 11,067 | 8,093 | 1,410 | | Minority Interest | (24) |
-
|
-
| (87) | | | | Net Income From Continuing Ops | 19,564 | 19,560 | 15,158 | 1,664 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,564 | 19,560 | 15,158 | 1,664 | | Preferred Stock And Other Adjustments | (19) | 24 | (5) |
-
| | | Net Income Applicable To Common Shares | $19,545 | $19,584 | $15,153 | $1,664 |
|
0.26% Nasdaq 0.00%
Income Statement
